21.20.0
Производство фармацевтических препаратов
152
Общество с ограниченной или дополнительной ответственностью
03877
Агентство по развитию фармацевтической отрасли при Министерстве здравоохранения Республики Узбекистан
1703401
Республика Узбекистан, Андижанская область, Андижан
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on arbitration cases
No data on participation in public procurement as a supplier or customer
Коротко о компании
MEGAVIT FARM has been operating since 2017 in the Производство фармацевтических препаратов industry. The director is SHAMSHIYEV DOSTONBEK ABDULAZIZ O‘G‘LI. The company belongs to the Microcompany category. Its primary activity is Производство фармацевтических препаратов. The company has 1 from $count_of_founders from other countries, one of whom owns a 100% stake. $count_of_licensing_text. The company has no registered property., $register_text, and 65 similar companies, indicating a highly competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on related organizations
No data on licenses
No data on real estate
No data on trademarks
Коротко о компании
MEGAVIT FARM has been operating since 2017 in the Производство фармацевтических препаратов industry. The director is SHAMSHIYEV DOSTONBEK ABDULAZIZ O‘G‘LI. The company belongs to the Microcompany category. Its primary activity is Производство фармацевтических препаратов. The company has 1 from $count_of_founders from other countries, one of whom owns a 100% stake. $count_of_licensing_text. The company has no registered property., $register_text, and 65 similar companies, indicating a highly competitive market.